ICHG 2019 Speakers
Dr Rebecca Painter
Gynaecologist and fellow in fetal maternal medicine
University of Amsterdam
Dr Painter is a gynaecologist and fellow in fetal maternal medicine at the University of Amsterdam, Academic Medical Centre. Her clinical interests focus on nutrition in pregnancy, and include maternal obesity, diabetes in pregnany and hyperemesis gravidarum.
In her PhD, she established that long term effects of maternal undernutrition during the Dutch Famine of 1944-45. Her current research interests include the long term health of children conceived by IVF and of those conceived by obese women. Her group recently conducted the first randomised controlled trial to study the utility of tube feeding in hyperemesis gravidarum.
Chair of Trustees, PhD Student
Pregnancy Sickness Support, Plymouth University
A three time hyperemesis gravidarum survivor, Caitlin Dean dedicates her time and energy in to raising awareness about the condition in the media, providing support to sufferers and writing prolifically on the subject through her Spewing Mummy blog, healthcare journals and magazines. As a Registered General Nurse and Chairperson for UK charity Pregnancy Sickness Support she is involved in research, pioneering services and health care professional education about HG. She has authored two books on the condition: Hyperemesis Gravidarum – The Definitive Guide for women, partners and healthcare professionals; and How to be an HG Hero for the children of women suffering.
Following her MSc in Clinical Research in 2016 in which she surveyed women's experiences of treatment for HG in the UK, Caitlin is currently undertaking a PhD to further the HG research agenda. Her particular interest is in the benefits of pre-pregnancy planning for subsequent HG pregnancies and prophylactic treatment.
Professor of Research
UCLA, USC and HER Foundation
Marlena Schoenberg Fejzo, Ph.D., is an American medical scientist and professor of research on Hyperemesis Gravidarum (HG) and gynecologic cancer. She received her Ph.D. from Harvard University in 1995 and currently has joint appointments at the University of California, Los Angeles and the University of Southern California. She has published peer-reviewed scientific articles on many diseases of women including ovarian cancer, breast cancer, multiple sclerosis, and discovered the first gene for uterine fibroids. She provided evidence for a genetic component to HG, is an advisor for the Hyperemesis Education and Research Foundation, and runs a study to identify genes and epidemiologic factors linked to HG.
Registrar in obstetrics and gynaecology and PhD student
University of Amsterdam
Dr Grooten is a registrar in obstetrics and gynaecology at the University of Amsterdam, Academic Medical Centre. She is conducting her PhD on hyperemesis gravidarum (HG), covering aetiologic markers, treatment options and offspring cardiometabolic consequences. She has just completed a nationwide randomised controlled trial investigating the effectiveness of early nasogastric tube feeding in HG (MOTHER trial) and is currently developing a large Delphi survey including multiple stakeholders to develop international consensus on HG definition and core outcomes for HG research (DCOHG project).
Professor Steve Robson
Professor of Fetal Medicine
Institute of Cellular Medicine
Stephen Robson MB BS MRCOG MD FRCP(Edin) is Professor of Fetal Medicine and a member of the Institute of Cellular Medicine at Newcastle University. He is Clinical Director of the NIHR Clinical Research Network in the North East and North Cumbria. His main research interests are: uterine cell signalling, mechanisms of myometrial quiescence and clinical trials in the area of high risk pregnancy and prenatal screening
Kimber Wakefield MacGibbon
Kimber Wakefield MacGibbon, Registered Nurse, is the co-founder and Director of the Hyperemesis Education and Research Foundation. In collaboration with the University of Southern California and the University of California Los Angeles, she has coauthored over two dozen papers on HG that study the short and long-term maternal and fetal impact of HG, as well as explore a genetic causation. She has spoken in Washington, DC at a congressional briefing on HG and authored numerous educational materials. She oversees the daily operations of the foundation and regularly assists clinicians, families and researchers to minimise the suffering and loss associated with HG.